Navigation Links
Clontech Laboratories, Inc. Releases the Xfect(TM) and Xfect(TM) Stem Transfection Reagents
Date:5/28/2009

MOUNTAIN VIEW, Calif., May 28 /PRNewswire/ -- Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced the upcoming (June 1, 2009) release of the Xfect(TM) and Xfect(TM) Stem transfection reagents. These novel transfection reagents are based on biodegradable nanoparticles that permit superior transfection efficiency of plasmid DNA into mammalian cells. For added ease of use, transfections can be carried out entirely in the presence of serum. Xfect shows high efficiency over a broad range of cell types, while Xfect Stem meets the highly specialized requirements for mouse embryonic stem cell transfections.

Carol Lou, General Manager of Clontech Laboratories, Inc., comments: "Clontech has a long history of leadership in developing technologies for gene delivery and expression. We identified a need for cost-effective, efficient and non-toxic transfection reagents, and responded with an innovative solution. We are pleased to announce the addition of Xfect transfection reagents to our wide range of established products, including our Lenti-X(TM) and Adeno-X(TM) viral delivery systems and vectors for Tet-On(R) Advanced- and ProteoTuner(TM)-based inducible expression."

Researchers recognize that effective, nontoxic DNA transfer is a vital first step in basic and applied research, including studies of gene regulation, protein expression, and function; the development of transgenic organisms; and therapeutic gene delivery. Clontech has a patent license from M.I.T. based on research by scientists at M.I.T. who screened more than 2,300 candidate polymers to identify novel biodegradable nanoparticles that facilitate exceptional transfection efficiency. Under the license, Clontech optimized two of the lead compounds from the screen to create the Xfect and Xfect Stem reagents.

About Clontech Laboratories, Inc.

Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara
'/>"/>

SOURCE Clontech Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Clontech Laboratories, Inc. Releases the ProteoTuner(TM) Systems
2. Clontech Laboratories, Inc. Recognizes the 2008 Winners of the Nobel Prize in Chemistry
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Methimazole Tablets USP, 5 mg and 10 mg
4. Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Additional Lawsuit Against Several Companies for Patent Infringement
5. Forest Laboratories, Inc. Announces Positive Results of Memantine Study of Once-Daily Formulation
6. Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
7. Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement
8. Forest Laboratories, Inc. and Laboratorios Almirall, S.A. to Host Webcast to Discuss Aclidinium Bromide Data Presentations at the American Thoracic Society Annual Congress
9. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 First Quarter Earnings
10. Caraco Pharmaceutical Laboratories, Ltd. Announces Resignation from Board of Directors of Jitendra Doshi and Appointment of GP Singh Sachdeva
11. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... TEL AVIV, Israel , July 23, 2014 ... Ltd ., a portfolio company of Trendlines ... with one of Israel,s ... (Logo: http://photos.prnewswire.com/prnh/20140121/666259-a) , Valentis,s technology combines ... from plant pulp waste, with additional nanoparticles to ...
(Date:7/23/2014)... , July 23, 2014 regulated information -- UCB ... and development pipeline with positive topline results from ... . This study was designed to evaluate the efficacy ... 200 mg/day, without titration) compared to placebo, as ... partial-onset seizures, not fully controlled despite treatment with ...
(Date:7/23/2014)... PARK, Calif. , July 23, 2014  Sofinnova ... investment firm, today announced the closing of Sofinnova Venture ... million and in excess of the initial fund target ... helping entrepreneurs build successful biotechnology companies. Consistent with recent ... with promising later stage clinical programs, along with select ...
(Date:7/23/2014)... July 23, 2014 OncLive® is ... Center has joined its Strategic Alliance Partnership program. ... Partnership program, UNC Lineberger will have the opportunity ... awareness of its cutting-edge research initiatives, community-directed cancer ... Lineberger will work with OncLive to educate their ...
Breaking Biology Technology:Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7Sofinnova Raises $500 Million Biotech Venture Fund 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 3
... out of a promising research breakthrough on Alzheimer's disease, ... hopes of commercializing an Alzheimer's-inhibiting drug. , ,Johnson and ... about four years ago by asking a simple question: ... protein thats been shown to kill human neurons in ...
... Representatives would decrease, but not eliminate, federal restrictions on ... mid-2001. , ,H.R. 810, the Stem Cell Research Enhancement ... Michael Castle of Delaware and a long list of ... Act by making human embryonic stem cells eligible for ...
... Johnson, a UW-Madison scientist, and his colleagues want to develop ... in Madison, named Mithridion. Also, Wisconsin legislators are introducing a ... of database breaches, and the UW's Science Expeditions will be ... March 26, 2005 Listen to this episode ...
Cached Biology Technology:Madison-based Mithridion seeks to capitalize on Alzheimer's breakthrough 2Madison-based Mithridion seeks to capitalize on Alzheimer's breakthrough 3Madison-based Mithridion seeks to capitalize on Alzheimer's breakthrough 4House may vote soon to relax stem-cell restrictions 2House may vote soon to relax stem-cell restrictions 3
(Date:7/23/2014)... Department of Defense recently awarded the STEMPREP Project ... to support its goal of increasing the number ... science-minded minority middle school students for the two-summer ... high school students with summer opportunities at research ... Caldwell Simmons School of Education and Human Development, ...
(Date:7/23/2014)... New research from North Carolina State University shows that ... the southeastern United States. One factor is that researchers ... produced by the gloomy scale insect a significant ... leads to 200 times more adult gloomy scales on ... plant-eating insects like the gloomy scale in cities, and ...
(Date:7/23/2014)... the young, are highly sensitive to temperature and to ... within a narrow range. Recently published research led by ... of Arts and Sciences, is the first to show ... in process similar to how humans and other mammals ... , "This study shows how workers effectively dissipate the ...
Breaking Biology News(10 mins):Department of Defense awards $2.6 million grant to SMU STEM program for minority students 2Urban heat boosts some pest populations 200-fold, killing red maples 2Urban heat boosts some pest populations 200-fold, killing red maples 3How honey bees stay cool 2
... ITHACA, N.Y. Genetic factors explain some of the ... and economic decisions such as preferences toward environmental ... with specific genetic variants are likely to be very ... University economics professor Daniel Benjamin. The research team ...
... at the Ottawa Hospital Research Institute (OHRI) and the University ... gene called Snf2l have brains that are 35 per cent ... and published in the prestigious journal Developmental Cell , ... may provide important insight into developmental disorders such as autism ...
... corn fields that line Midwestern roads may one day ... fertilizer and other inputs, thanks to a fungicide commonly ... University assistant professor of plant biochemical and molecular genetics, ... in corn plants would create tiny versions that only ...
Cached Biology News:New evidence that many genes of small effect influence economic decisions and political attitudes 2Mice with big brains provide insight into brain regeneration and developmental disorders 2Tiny plants could cut costs, shrink environmental footprint 2
ANTI STENOTROPHOMONAS MALTOPHILIA...
... an essential component of the COP9 signalosome ... cellular and developmental processes. The CSN complex ... (Ubl) conjugation pathway by mediating the deneddylation ... ligase complexes. The complex is also involved ...
6B9...
Taq DNA Polymerase (T. aquaticus), 250 units. For PCR and other procedures requiring DNA polymerase activity at elevated temperatures. Category: Nucleotides & Enzymes & Biochemicals, Modifying Enzyme...
Biology Products: